These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2261202)
1. Prognostic factors in head and neck non-Hodgkin's lymphoma with special reference to serum lactic dehydrogenase and serum copper. Hisamitsu S; Shibuya H; Hoshina M; Horiuchi J Acta Oncol; 1990; 29(7):879-83. PubMed ID: 2261202 [TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors in non-Hodgkin's lymphoma of Waldeyer's ring and the lymph nodes of the neck]. Kobayashi Y; Ogino T; Hayashi T; Nonaka S; Harabuchi Y Nihon Jibiinkoka Gakkai Kaiho; 2000 Jun; 103(6):761-9. PubMed ID: 10897589 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma. Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma]. Raemaekers JM; Snoeijen JJ; Bogman MJ; Rutten E; Strijk SP; Manni JJ Ned Tijdschr Geneeskd; 1993 Apr; 137(16):815-20. PubMed ID: 8487885 [TBL] [Abstract][Full Text] [Related]
5. [Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck--multivariate analysis of prognostic factors and evaluation of therapeutic modalities]. Tomita T; Fujii M; Imanishi Y; Kanke M; Kanzaki J; Ohno Y; Tokumaru Y; Inuyama Y Nihon Jibiinkoka Gakkai Kaiho; 1999 Jun; 102(6):809-17. PubMed ID: 10429435 [TBL] [Abstract][Full Text] [Related]
7. Treatment of localized non-Hodgkin's lymphomas of the head and neck: focusing on cases of non-lethal midline granuloma. Sakata K; Hareyama M; Oouchi A; Sido M; Nagakura H; Morita K; Harabuchi Y; Kataura A; Hinoda Y Radiat Oncol Investig; 1998; 6(4):161-9. PubMed ID: 9727875 [TBL] [Abstract][Full Text] [Related]
8. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study. Gordon LI; Andersen J; Colgan J; Glick J; Resnick GD; O'Connell M; Cassileth PA Cancer; 1995 Feb; 75(3):865-73. PubMed ID: 7530168 [TBL] [Abstract][Full Text] [Related]
10. Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin's lymphoma. Dumontet C; Drai J; Bienvenu J; Berard EN; Thieblemont C; Bouafia F; Bayle F; Moullet I; Salles G; Coiffier B Leukemia; 1999 May; 13(5):811-7. PubMed ID: 10374888 [TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for primary non-Hodgkin's lymphoma of the head and neck. Teshima T; Chatani M; Inoue T; Miyahara H; Tsuruta Y; Yoshino K; Sato T; Shibata H Radiat Med; 1991; 9(1):29-34. PubMed ID: 1852902 [TBL] [Abstract][Full Text] [Related]
12. Head and neck extranodal lymphoma in a single institute: a 17-year retrospective analysis. Chi HS; Lee KW; Chiang FY; Tai CF; Wang LF; Yang SF; Lin SF; Kuo WR Kaohsiung J Med Sci; 2012 Aug; 28(8):435-41. PubMed ID: 22892165 [TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma. Sasaki K; Niitsu N Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056 [TBL] [Abstract][Full Text] [Related]
14. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Urquhart A; Berg R Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605 [TBL] [Abstract][Full Text] [Related]
15. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group. Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986 [TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphoma of the head and neck: a 30-year experience at the University of Florida. Nathu RM; Mendenhall NP; Almasri NM; Lynch JW Head Neck; 1999 May; 21(3):247-54. PubMed ID: 10208668 [TBL] [Abstract][Full Text] [Related]
17. Age-related prognostic factor analysis in non-Hodgkin's lymphoma. Maksymiuk AW; Haines C; Tan LK; Skinnider LF Can J Oncol; 1996 Jun; 6(1):435-42. PubMed ID: 8853516 [TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma]. Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038 [TBL] [Abstract][Full Text] [Related]
19. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma]. Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831 [TBL] [Abstract][Full Text] [Related]
20. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients]. García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]